论文部分内容阅读
本文观察急性心肌梗塞(AMI)溶栓过程中的室性心律失常,评估溶栓早期静脉注射β-受体阻滞剂的抗心律失常作用。 AMI107例,男87例、女20例,年龄59±12(32～84)岁。其中前壁58例、下壁49例,均无近期手术、冠脉搭桥、溃疡病、抗凝治疗史以及严重高血压等溶栓治疗禁忌症。症状出现后的6小时内分别给予尿激酶原(59例)、酰基化纤溶酶原链激酶原激活剂复合物(39例)、组织型纤溶酶原激活剂(5例)、尿激酶(4例)进行溶栓治疗。之后,静注肝素7500
This article observes ventricular arrhythmia during thrombolysis in patients with acute myocardial infarction (AMI) and evaluates the antiarrhythmic effects of early intravenous β-blockade of thrombolytic therapy. AMI107 cases, 87 males and 20 females, aged 59 ± 12 (32 to 84) years of age. There were 58 cases of anterior wall and 49 cases of inferior wall without any contraindications to thrombolytic therapy such as recent surgery, coronary artery bypass grafting, ulcer disease, anticoagulant therapy and severe hypertension. Urokinase (59 cases), acylated plasminogen streptokinase activator complex (39 cases), tissue-type plasminogen activator (5 cases), urokinase 4 cases) for thrombolytic therapy. After intravenous heparin 7500